AM06
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AM06 Trademark

Serial Number: 79422449

AM06 is a trademark filed by Guangzhou Zhiyi Biotechnology Co., Ltd. on January 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 32 (Light Beverages), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Guangzhou Zhiyi Biotechnology Co., Ltd.

Room 301, Building A, No. 2 Ruitai Road,

Entity Type: 98

Trademark Details

Filing Date

January 17, 2025

Registration Date

Not Registered

Goods & Services

Cocoa; coffee; tea; biscuits; high-protein cereal bars; bread; ice cream; pastries; Confectionery, namely, frozen confectionery, almond confectionery, chocolate confectionery, iced confectionery, nut confectionery, peanut confectionery and confectionery made of sugar; Confectionery, namely, cake, fruit jelly candy; frozen yogurt; yogurt-covered fruit, Dessert mousses; flavored jelly crystals for making jelly confectionery; honey

Advertising services; online advertising on a computer network; commercial administration of the licensing of the goods and services of others; market research studies; commercial information; import-export agency services; sales promotion for others; marketing services; provision of an online marketplace for buyers and sellers of goods and services; Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies

Whey beverages; Non-alcoholic beverages containing fruit juices; Non-alcoholic beverages with tea flavor; Non-alcoholic malt beverages; Non-alcoholic carbonated beverages; Non-alcoholic beer-flavored beverages; Non-alcoholic water-based beverages; Non-alcoholic beverages flavored with coffee; Non-alcoholic drinks made from seaweed; Aloe vera beverages, non-alcoholic; Honey-based beverages, non-alcoholic; fruit beverages; fruit juice; Flavored protein-enriched water beverages; Non-alcoholic vegetable juice beverages; Green vegetable juice beverages; protein-enriched sports beverages; smoothies; plant-based beverages, namely, non-alcoholic fruit juice beverages; Preparations for making non-alcoholic fruit-flavored beverages; Preparations for making non-alcoholic carbonated beverages

Cultures of microorganisms for medical or veterinary use; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of kidney disease; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of pain, cancer and tumors; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of pulmonary hypertension and pulmonary arterial hypertension; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia and hypothyroidism; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of gastro-intestinal diseases; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; Drugs for medical purposes, namely, pharmaceutical anxiolytic medications; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of liver diseases and disorders; Drugs for medical purposes, namely, oral sprays containing cannabis for relieving depression; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of blood disorders, inflammation, sepsis and alopecia; Drugs for medical purposes, namely, psychiatric pharmaceutical preparations for the prevention and treatment of mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; probiotic preparations for medical use; medicinal drinks; dietary supplements to stimulate the growth of probiotics; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; nutritional supplements; food for babies

Fruits, tinned; cheese; milk; milk products excluding ice cream, ice milk and frozen yogurt; milk beverages, milk predominating; soya milk being milk substitute; seaweed extracts for food; Tofu products, namely, tofu, tofu-based snack food, tofu patties and tofu skin; fruit-based snack food; snack food, fruit and vegetable-based

Filing History

REFUSAL PROCESSED BY IB
May 28, 2026 RFNT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 1, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 1, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 1, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 23, 2026 DOCK
ASSIGNED TO EXAMINER
Apr 23, 2026 DOCK
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 6, 2026 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 24, 2026 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2026 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 30, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 13, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 12, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 28, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 24, 2025 REPR